State Board of Administration of Florida Retirement System’s Ocular Therapeutix OCUL Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$266K	Hold	31,418	–	–	﹤0.01%	1769
2025 Q4	$381K	Hold	31,418	–	–	﹤0.01%	1662
2025 Q3	$367K	Hold	31,418	–	–	﹤0.01%	1677
2025 Q2	$292K	Hold	31,418	–	–	﹤0.01%	1755
2025 Q1	$230K	Hold	31,418	–	–	﹤0.01%	1822
2024 Q4	$268K	Hold	31,418	–	–	﹤0.01%	1806
2024 Q3	$273K	Hold	31,418	–	–	﹤0.01%	1840
2024 Q2	$215K	Buy	31,418 +140	+0.4%	+$864	﹤0.01%	1916
2024 Q1	$165K	Sell	31,278 -140	-0.4%	-$994	﹤0.01%	1974
2023 Q4	$140K	Hold	31,418	–	–	﹤0.01%	2180
2023 Q3	$98.7K	Buy	31,418 +140	+0.4%	+$573	﹤0.01%	2224
2023 Q2	$161K	Hold	31,278	–	–	﹤0.01%	2163
2023 Q1	$165K	Hold	31,278	–	–	﹤0.01%	2054
2022 Q4	$87.9K	Hold	31,278	–	–	﹤0.01%	2227
2022 Q3	$130K	Hold	31,278	–	–	﹤0.01%	2158
2022 Q2	$126K	Buy	31,278 +10	+0%	+$38	﹤0.01%	2218
2022 Q1	$155K	Hold	31,268	–	–	﹤0.01%	2210
2021 Q4	$218K	Buy	31,268 +151	+0.5%	+$1.17K	﹤0.01%	2185
2021 Q3	$311K	Hold	31,117	–	–	﹤0.01%	2085
2021 Q2	$441K	Buy	31,117 +6,381	+26%	+$97K	﹤0.01%	1942
2021 Q1	$406K	Hold	24,736	–	–	﹤0.01%	1919
2020 Q4	$512K	Buy	24,736 +8,760	+55%	+$130K	﹤0.01%	1762
2020 Q3	$122K	Hold	15,976	–	–	﹤0.01%	2192
2020 Q2	$133K	Buy	15,976 +3,506	+28%	+$23.2K	﹤0.01%	2170
2020 Q1	$62K	Buy	12,470 +900	+8%	+$4.44K	﹤0.01%	2130
2019 Q4	$46K	Hold	11,570	–	–	﹤0.01%	2254
2019 Q3	$35K	Hold	11,570	–	–	﹤0.01%	2253
2019 Q2	$51K	Hold	11,570	–	–	﹤0.01%	2288
2019 Q1	$46K	Hold	11,570	–	–	﹤0.01%	2304
2018 Q4	$46K	Hold	11,570	–	–	﹤0.01%	2313
2018 Q3	$80K	Hold	11,570	–	–	﹤0.01%	2363
2018 Q2	$78K	Buy	11,570 +260	+2%	+$1.79K	﹤0.01%	2370
2018 Q1	$74K	Hold	11,310	–	–	﹤0.01%	2362
2017 Q4	$50K	Hold	11,310	–	–	﹤0.01%	2394
2017 Q3	$70K	Hold	11,310	–	–	﹤0.01%	2400
2017 Q2	$105K	Buy	+11,310	New	+$109K	﹤0.01%	2376

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Board of Administration of Florida Retirement System's OCUL Position: Q1 2026 in Review

State Board of Administration of Florida Retirement System held its Ocular Therapeutix (OCUL) position steady in Q1 2026 at 31,418 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #1769.

State Board of Administration of Florida Retirement System first reported a position in OCUL in Q2 2017 and has held it in 36 quarters since. The position peaked at $512K in Q4 2020. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

State Board of Administration of Florida Retirement System held 31,418 shares of Ocular Therapeutix worth $266K as of Q1 2026.
State Board of Administration of Florida Retirement System left its Ocular Therapeutix share count unchanged in Q1 2026.
Ocular Therapeutix made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q1 2026, its #1769 holding.
State Board of Administration of Florida Retirement System first reported a position in Ocular Therapeutix in Q2 2017 and has held it in 36 quarters since.
State Board of Administration of Florida Retirement System's Ocular Therapeutix position peaked at $512K in Q4 2020.
269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2026, filed 8 May 2026.